We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

NOV 11 2020

Legal Opinion: BPCIA Is Likely to Survive Latest ACA Challenge - The Center for Biosimilars

Drew Hillier, associate in the firm's Litigation section, co-authored an article for The Center for Biosimilars, “Legal Opinion: BPCIA Is Likely to Survive Latest ACA Challenge.”